JAMIESON HEALTH CENTER

·         A patient case study by Dr. Robert Coben, 2007.

ADD/ADHD.

Recent research and approval from the Amer­i­can Acad­emy of Pedi­atrics shows that qEEG guided Neurofeedback is a very effective treatment for ADD/ADHD. See the following clinical studies:

·         Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis, Arns M, de Ridder S, Strehl U, Breteler M, Coenen A., Clin EEG Neurosci. 2009 Jul;40(3):180-9: This 2009 ADHD meta-analysis study concluded that qEEG guided neurofeedback can indeed be considered an Evidence-Based treatment for ADHD. This analysis included 15 studies and 1194 ADHD patients.  The results show that qEEG guided neurofeedback has large and clinically significant effects on impulsivity, inattention and hyperactivity.

·     American Academy of Pediatrics considers (EEG) Biofeedback now a “Level 1 — Best Support” Intervention for Attention & Hyperactivity Behaviors, October 2012.
Prac­tice­Wise, the com­pany that main­tains the Amer­i­can Acad­emy of Pedi­atrics “Evidence-based Child and Ado­les­cent Psycho-social Inter­ven­tions” has just announced it will ele­vate (EEG) biofeed­back to “Level 1 — Best Sup­port” as an inter­ven­tion for Atten­tion & Hyper­ac­tiv­ity Behav­iors in the next edi­tion.

·         FDA permits marketing of first brain wave test to help assess children and teens for ADHD, July 2013.

The NEBA System is a 15- to 20-minute non-invasive EEG test that calculates the ratio of two standard brain wave frequencies, known as theta and beta waves. The theta/beta ratio has been shown to be higher in children and adolescents with ADHD than in children without it.

Our qEEG brain map system is a more comprehensive brain wave super test, which includes the analysis of theta/beta ratios.

·         Electroencephalographic biofeedback in the treatment of attention-deficit/hyperactivity disorder. Monastra VJ & co., 2005

·         EEG Biofeedback in the Treatment of Attention Deficit/Hyperactivity Disorder, a review by Patrick N. Briel, BS., 2007

·         A controlled study of the effectiveness of EEG biofeedback training on-children with attention deficit hyperactivity disorder, 2005, Xiong & Co, J Huazhong Univ Sci Technolog Med Sci. 2005;25(3):368-70.

·         Treatment of attention deficit hyperactivity disorder with neurotherapy, Clin Electroencephalog, 2000 Jan;31(1):30-7.

·         Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T.O.V.A. scores, behavioral ratings, and WISC-R performance, Lubar, Swartwood & Co, University of Tennessee, 1995.

Asperger’s Disease.

Clincial studies show that Neurofeedback is an effective therapy for Asperger’s. See the following clinical studies:

·         Functional Neuroanatomy and the Rationale for Using EEG Biofeedback for Clients with Asperger’s Syndrome, Lynda Thompson, Michael Thompson, Andrea Reid, 2009

Reactive Attachment Disorders (RAD)

qEEG Neurofeedback is among the most promising modalities for the treatment of child and adolescent psychological disorders. Interest in neurofeedback’s potential as a therapeutic intervention for pediatric populations is heightened by concerns regarding the uncertain long-term effects of psychiatric and stimulant medications on the developing brain.

Furthermore, for children with histories of relational trauma, attachment disorders, or RAD, conventional relationship-based therapies (including cognitive therapies and playbased therapies) have demonstrated limited clinical success. It would appear that children with histories of traumatic attachment struggle fundamentally with self-regulatory challenges.

qEEG biofeedback may teach children to self-regulate brain rhythmicity, which in turn may impact their ability to adaptively manage physiological and emotional arousal states. Because poor self-regulation of arousal is central to the vast majority of the behavioral difficulties experienced by children with traumatic attachment histories, neurofeedback has the potential to affect global improvements in the typical problem areas of attention, aggression, impulse control, hypervigilance, classroom learning, empathy and trust formation, sleep, hyperactivity, etc. The mechanisms and objectives of EEG biofeedback would seem to be expressly appropriate for the behavioral and neurophysiological needs of this population.

The below pilot study using a clinical case series represents an initial step in the empirically-based investigation of neurofeedback treatment for children with RAD symptoms.

·         QEEG-Guided Neurofeedback for Children with Histories of Abuse and Neglect: Neurodevelopmental Rationale and Pilot Study; Lark Huang-Storms; Eugenia Bodenhamer-Davis; Richard Davis; Janice Dunn, 2007

Depression.

Several clinical studies have shown that asymmetry neurofeedack therapy helps heal depression and reverses its underlying biological predisposition.  See the following clinical studies:

·         Is Alpha Wave Neurofeedback effective with randomized clinical trials in depression. A pilot study, Sung Won Choi & Co., 2010

·         Clinical use of an alpha asymmetry neurofeedback protocol in the treatment of mood disorders, Elsa Baehr & Co.

Anxiety.

Clincial studies show that Neurofeedback is an effective therapy for anxiety. Although anxiety often involves excess right frontal beta brain wave activity, clinical experience has shown that a qEEG assessment is often invaluable because the excess of fast beta activity may be in other locations. Someone who obsessively worries may have this beta excess along the midline or in the center of the top of the head at an electrode location known as Cz. In other cases, the excess beta may be in the parietal area.

With anxiety patients, neurofeedback training often is done eyes closed while listening to auditory feedback such as classical music, and in a sense it resembles high-technologic meditation training. For more about qEEG neurofeedback for anxiety, read the following clinical studies:

·         Neurofeedback with anxiety and affective disorders, D. Corydon Hammond, PhD, ABEN/ECNS, 2005

OCD.

Compelling evidence exists for a neurophysiologic basis for obsessive-compulsive disorder (OCD). A large number of PET  studies have found increased blood flow and metabolism in the mediofrontal, anterior cingulate, right frontal, or orbitofrontal areas, which implicates a cortico-striato-thalamocortical network. Functional abnormalities also have been documented in a large number of quantitative EEG (qEEG) studies and evoked potential studies.

OCD seems to be somewhat heterogeneous, however, with at least two qEEG subtypes that have been found. Prichep et al and Kuskowski et al found a group with excess alpha brain waves throughout most of the head, with frontal excess beta, whereas another subgroup has an excess of theta activity, particularly in frontal and posterior temporal areas.

Clinical experience in conducting qEEG assessment with patients with OCD also has shown that excess beta activity is often found along the midline, in cortical areas approximately over the anterior cingulate. Read the entire study at:

·         Neurofeedback with anxiety and affective disorders, D. Corydon Hammond, PhD, ABEN/ECNS, 2005

Neurofeedback Training.

·         Neurofeedback Training Induces Changes in White and Gray Matter, J. Ghaziri, A. Tucholka, V. Larue, M. Blanchette-Sylvestre, G. Reyburn, G. Gilbert, J. Lévesque and M. Beauregard, Clin EEG Neurosci, March 2013

·         Neurofeedback and the Brain, Jay D. Gunkelman1,3 and Jack Johnstone, Journal of Adult Development, Vol. 12, Nos. 2/3, August 2005

·         Comprehensive Neurofeedback Bibliography, D. Corydon Hammond, PhD, Professor, Physical Medicine & Rehabilitation, University of Utah School of Medicine

Alpha-Theta Deep States Training.

·         A theory of alpha/theta neurofeedback, creative performance enhancement, long distance functional connectivity and, psychological integration, John Gruzelier, July 2008

Other.

·         National Institute of Mental Health Moves Beyond DSM

The largest mental health research organization in the world announced it will depart from the Diagnostic and Statistical Manual of Mental Disorders (DSM), the "Bible" of modern psychiatry, in favor of researching new diagnoses based on biomarkers, such as imaging and genetics, May 2013.

Disclaimer: A qEEG brain map is not intended for clinical diagnosis, but for the purpose of clinical practice of qEEG neurofeedback. A nutritional evaluation is not a substitute for an official clinical diagnosis, rather it is intended for the development of nutritional protocols.